Incidence And Prognosis Of Metastatic Breast Cancer: A Population-based Data Linkage Study
Funder
National Health and Medical Research Council
Funding Amount
$97,700.00
Summary
This project will provide the first Australian population-based estimates of metastaticbreast cancer (MBC) incidence and survival in women with an initial diagnosis of early stage cancer that reflect current treatment practices. This evidence will help: women with MBC and their clinicians to make decisions about treatment and plan supportive care; researchers planning trials of MBC therapies, and future planning of cancer services.
Temporal Trends In The Incidence, Site And Survival Of Metastatic Breast Cancer In Australia
Funder
National Health and Medical Research Council
Funding Amount
$190,494.00
Summary
There have been major advances in breast cancer treatment over the last decade. This project will use information collected from the NSW cancer registry and hospitals to report on changes in the type and risk of breast cancer spread and survival for women with a new diagnosis of breast cancer before and after new treatments introduced since 2005. This information is essential for doctors to provide women with up-to-date information; and for planning appropriate health services and research.
Using Linked Population-based Health-related Datasets To Optimise Cancer Care And Reduce Survival Disparities.
Funder
National Health and Medical Research Council
Funding Amount
$850,941.00
Summary
In partnership with the Victorian Department of Health and Human Services, we will use detailed health data from various sources to assess how care is provided to people with cancer and determine why some have better survival than others. The findings will be used to change government policy and clinical practice in order to improve cancer outcomes for those who fair worse. We will establish a data bank to enable this information to be used to improve services into the future.
Chronic Disease Epidemiology In Different Populations: Risk Factors, Detection And Prevention
Funder
National Health and Medical Research Council
Funding Amount
$621,458.00
Summary
To investigate causes, detection and prevention of diabetes, cardiovascular disease, and kidney disease in Aboriginal and international populations, I will maintain a long-term cohort with a 20-year follow-up in Aboriginal people and to analyse several large repeated cross-sectional data collected over 25 years in China. For the next 5 years, I will continue to to provide critical epidemiological evidence for the development of health policies and clinical guidelines related to chronic diseases ....To investigate causes, detection and prevention of diabetes, cardiovascular disease, and kidney disease in Aboriginal and international populations, I will maintain a long-term cohort with a 20-year follow-up in Aboriginal people and to analyse several large repeated cross-sectional data collected over 25 years in China. For the next 5 years, I will continue to to provide critical epidemiological evidence for the development of health policies and clinical guidelines related to chronic diseases in different populations.Read moreRead less
Generational And Developmental Pathways Of Childhood And Adolescent Obesity: A Three Generation Cohort Study
Funder
National Health and Medical Research Council
Funding Amount
$1,281,100.00
Summary
There are no community-based follow-up (FU) studies of three generations able to examine the impact of earlier generational factors on the developmental pathways of obesity in third generation. The Mater-University of Queensland Study of Pregnancy (MUSP) cohort now has data covering the grandmothers' (GI) reproductive life course and a FU of their children (GII) into adulthood. We now propose a new study of the "children-of-the-children" who are the grandchildren (GIII) of GI and children of GII
Using Epidemiological Methods To Investigate How Genetic, Environmental And Lifestyle Factors Influence Cancer Incidence And Cancer Survivorship; And Translation Into Cancer Prevention And Policy Outcomes
Funder
National Health and Medical Research Council
Funding Amount
$421,747.00
Summary
This research program focuses on investigating genetic, environmental and lifestyle causes of cancer, preventing new cases of cancer, and improving outcomes after a cancer diagnosis, particularly for melanoma and gynaecological cancer, which carry a heavy burden in the Australian population. The research will also inform the best allocation of health system resources for cancer control, and ensure translation of research findings into cancer prevention, clinical practice and policy outcomes.
Epidemiology Of Allergic Diseases And The Role Of Early Life Eczema
Funder
National Health and Medical Research Council
Funding Amount
$416,306.00
Summary
Eczema prevents our children from getting a healthy start to life, increases their risk of developing asthma and hay-fever, and we don’t know how to prevent this condition. Dr. Lowe will help identify causes and the outcomes of eczema and allergic diseases in early life, by using a number of important research projects. This research includes an intervention trial that aims to prevent the development of allergic disease and sensitisation, which Dr Lowe leads
Cancer Epidemiology In High-risk Populations And Complex Cancers
Funder
National Health and Medical Research Council
Funding Amount
$451,716.00
Summary
My research program aims to better understand the causes of cancer and factors that influence outcomes after cancer diagnosis. It employs classical and innovative cancer epidemiology and includes large-scale studies of cancer incidence, survival and risk factors in people with immune dysfunction. It also includes studies of lymphoid malignancies and ‘cancer of unknown primary’ origin. The research program aims to build an evidence base for interventions that will reduce the burden of cancer nati ....My research program aims to better understand the causes of cancer and factors that influence outcomes after cancer diagnosis. It employs classical and innovative cancer epidemiology and includes large-scale studies of cancer incidence, survival and risk factors in people with immune dysfunction. It also includes studies of lymphoid malignancies and ‘cancer of unknown primary’ origin. The research program aims to build an evidence base for interventions that will reduce the burden of cancer nationally and internationally.Read moreRead less
Congenital Cytomegalovirus: Understanding The Long-term Outcomes And Identifying Opportunities For Secondary Prevention
Funder
National Health and Medical Research Council
Funding Amount
$318,768.00
Summary
Cytomegalovirus is a herpesvirus that can be transmitted from mother to baby during pregnancy. Congenital cytomegalovirus (cCMV) can cause damage to the developing central nervous system leading to long-term disabilities including cerebral palsy and hearing loss. This epidemiological research program seeks to investigate cCMV risk factors and burden, opportunities for early detection of neuro-developmental disabilities and to study the effects of postnatal antiviral therapies in this population.